Skip to main content
Terug
Watch Compare

LeonaBio, Inc.

Datakwaliteit: 83%
LONA
Nasdaq Manufacturing Chemicals
€ 9,69
▲ € 0,15 (1,57%)
Marktkapitalisatie: 91,94 M
Prijs
€ 9,79
Marktkapitalisatie
91,94 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -45,76 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-359,39%
Onder sectorgemiddelde (-53,34%)
ROIC-270,16%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio9,70
Interest CoverageN/A

Waardering

PE (TTM)
-0,87
Boven sectorgemiddelde (-1,47)
P/B Ratio3,43
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -0,9 -1,5
P/B 3,4 1,6
ROE % -359,4 -53,3
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Koersdoel Analisten

1 analist
Buy
Huidig
€ 9,69
+65.1%
Koersdoel
€ 16,00
€ 16,00
€ 16,00
€ 16,00
Vooruitzicht
Forward WPA -€ 2,32
Omzet Sch. 0,0

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 2,32
-€ 2,45 – -€ 2,18
 0,0 2
FY2026 -€ 5,02
-€ 6,95 – -€ 2,90
 0,0 3

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 1,27 -€ 18,92 -1393,7%
Q32025 -€ 1,22 -€ 1,68 -37,7%
Q22025 -€ 1,40 -€ 1,80 -28,6%
Q12025 -€ 2,40 -€ 2,30 +4,2%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -105,61 M
ROE -359,39% ROA -322,09%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -45,76 M
ROIC -270,16% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 9,70
Interest Coverage N/A Asset Turnover N/A
Working Capital 24,24 M Tangible Book Value 26,79 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,87 Forward P/E N/A
P/B Ratio 3,43 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -49,77%
Market Cap 91,94 M Enterprise Value 71,07 M
Per Share
EPS (Diluted TTM) -24,70 Revenue / Share N/A
FCF / Share -4,87 OCF / Share -4,87
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 43,33%
SBC-Adj. FCF -53,34 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -105,61 M -96,94 M -117,67 M -95,64 M -54,85 M
EPS (Diluted) -24,70 -2,52 -3,09 -2,53 —
Gross Profit — — — — —
Operating Income -102,27 M -100,90 M -125,47 M -104,02 M -64,02 M
EBITDA — — — — —
R&D Expenses 17,50 M 70,68 M 93,79 M 61,46 M 42,79 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — 3.000,0
Income Tax 0,0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 92,15 M 58,78 M 160,25 M 258,15 M 332,01 M
Total Liabilities 64,36 M 13,94 M 30,06 M 23,02 M 10,92 M
Shareholders' Equity 27,79 M 44,84 M 130,19 M 235,14 M 321,08 M
Total Debt — — — — —
Cash & Equivalents 69,28 M 48,44 M 90,58 M 95,97 M 110,54 M
Current Assets 89,46 M 54,84 M 154,73 M 207,53 M 260,80 M
Current Liabilities 47,50 M 13,14 M 28,84 M 21,43 M 9,29 M